61-75 of 166
Innovations in IgAN Care: Examining the Evolving Treatment Landscape
On the Frontlines of IgA NephropathyInnovations in IgAN Care: Examining the Evolving Treatment Landscape
The Future of IgA Nephropathy: Why Biomarkers Matter
On the Frontlines of IgA NephropathyThe Future of IgA Nephropathy: Why Biomarkers Matter
Investigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
Clinician's RoundtableInvestigating the Potential Link Between Chronic Tonsillitis and IgA Nephropathy
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Real-World Data on Treatment Choices for mccRCC
Project Oncology®Real-World Data on Treatment Choices for mccRCC
- advertisement
Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Project Oncology®Nephrotoxicity in the Crosshairs: Optimizing Renal Cancer Care with Kidney Preservation
Diabetes and CKD: Strategies for Diagnosis and Treatment
Diabetes DiscourseDiabetes and CKD: Strategies for Diagnosis and Treatment
Trimethylamine N-Oxide and CKD: A Concerning Link
Clinician's RoundtableTrimethylamine N-Oxide and CKD: A Concerning Link
Personalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI
KDIGO Conversations in NephrologyPersonalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKI
Stratifying the Risk of Persistent AKI and Clinical Practice
KDIGO Conversations in NephrologyStratifying the Risk of Persistent AKI and Clinical Practice
Extracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices
KDIGO Conversations in NephrologyExtracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best Practices
- advertisement
Improving CKD Patient Outcomes with SGLT2 Inhibitors
Clinician's RoundtableImproving CKD Patient Outcomes with SGLT2 Inhibitors
Improving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
Clinician's RoundtableImproving CKD Awareness: Emphasizing the Risk in Patients Who Are Unaware
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
